文献速递其他结缔组织病

上海仁济硬皮病纵向队列中发病年龄与系统性硬化症特征的关系

Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC).
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

基于仁济硬皮病纵向队列(Renji-SLOC)390例SSc患者,按发病年龄分为早发(<40岁,n=73)、标准(40-60岁,n=219)和晚发(>60岁,n=98)三组,比较基线血清学与临床特征并对131例患者行血浆蛋白质组分析。早发和晚发组dcSSc比例及mRSS均高于标准组;早发组严重皮肤受累和ILD风险升高,晚发组心肺、胃肠道和关节受累风险升高;中位随访15个月未见进展差异。

要点

  • 早发组dcSSc比例42.5%、晚发组36.7%,均高于标准组23.3%(P=0.002)。
  • 早发组严重皮肤受累OR=2.34、ILD OR=2.35(均P=0.005)。

核心结论

  • 非标准发病年龄预测SSc不同的器官特异性风险,早发患者需优先关注皮肤和肺部监测,晚发患者需警惕心肺和胃肠道并发症。
  • 蛋白质组学特征从机制上解释了这种表型异质性。

研究设计与样本

  • 前瞻性Renji-SLOC队列中390例SSc患者,按发病年龄分层:早发(<40岁,n=73)、标准(40-60岁,n=219)、晚发(>60岁,n=98)。
  • 比较基线血清学/临床数据,并对131例患者行血浆蛋白质组分析。

主要发现

  • 早发组dcSSc 42.5% vs 标准组23.3% vs 晚发组36.7%(P=0.002)。
  • mRSS:早发组7.0(9.0)vs 标准组4.0(6.0)vs 晚发组6.0(14.0),P=0.002。
  • 早发组严重皮肤受累(mRSS>7)OR=2.34(P=0.005),ILD OR=2.35(P=0.005)。
  • 晚发组ILD OR=1.93(P=0.016)、PAH OR=3.46(P<0.001)、舒张功能障碍OR=3.11(P<0.001)、体重下降OR=2.67(P=0.043)、关节受累OR=1.68(P=0.038)。
  • 中位随访15个月未见进展差异;蛋白质组分析质控后检测909种蛋白,早发组20种上调蛋白与严重皮肤受累和肺纤维化相关,晚发组90种上调蛋白富集于细胞外基质相关蛋白、ILD相关生物标志物及SSc进展和并发症标志物。

关键数值与推荐

  • 早发组严重皮肤受累(mRSS>7)OR=2.34(P=0.005)。
  • 早发组ILD OR=2.35(P=0.005)。
  • 晚发组ILD OR=1.93(P=0.016)、PAH OR=3.46(P<0.001)、舒张功能障碍OR=3.11(P<0.001)。
  • 晚发组体重下降OR=2.67(P=0.043)、关节受累OR=1.68(P=0.038)。

临床怎么用

  • 早发患者需优先进行皮肤和肺部监测。
  • 晚发患者需警惕心肺和胃肠道并发症。
  • 非标准发病年龄患者需加强器官特异性表现的监测。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to investigate associations between age at SSc onset and serologic, clinical, and proteomic characteristics in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC). METHODS: We analysed 390 SSc patients from the prospective Renji-SLOC cohort, stratified by onset age: early-onset (<40 years, n = 73), standard-onset (40-60 years, n = 219) and late-onset (>60 years, n = 98). Baseline serologic/clinical data were compared. Plasma proteomic profiling was performed for 131 patients. RESULTS: Early- and late-onset groups had higher percentages of dcSSc (early-onset SSc 42.5% vs standard-onset SSc 23.3% vs late-onset SSc 36.7%, P = 0.002) and elevated modified Rodnan Skin Score (mRSS) [early-onset SSc 7.0 (9.0) vs standard-onset SSc 4.0 (6.0) vs late-onset SSc 6.0 (14.0), P = 0.002]. Early-onset patients showed increased risks of severe skin involvement (mRSS > 7: OR = 2.34, P = 0.005) and interstitial lung disease (ILD) (OR = 2.35, P = 0.005). Late-onset patients had higher cardiopulmonary (ILD: OR = 1.93, P = 0.016; pulmonary arterial hypertension: OR = 3.46, P < 0.001; diastolic dysfunction: OR = 3.11, P < 0.001), gastrointestinal (weight loss: OR = 2.67, P = 0.043), and joint involvement risks (OR = 1.68, P = 0.038). No progression differences were observed during the median follow-up period of 15 months. Proteomic analysis of 131 patients detected a total of 909 proteins following quality control, with early-onset patients showing 20 upregulated proteins linked to severe cutaneous involvement and pulmonary fibrosis, while late-onset patients exhibited 90 upregulated proteins enriched in extracellular matrix-associated proteins, ILD-related biomarkers and SSc progression and complication markers. CONCLUSION: Non-standard onset age predicts distinct organ-specific risks in SSc. Early-onset patients require prioritizing of cutaneous and pulmonary monitoring, while late-onset patients require vigilance for cardiopulmonary and gastrointestinal complications. Proteomic signatures mechanistically underlie this phenotypic heterogeneity. Patients with non-standard onset age require enhanced surveillance for organ-specific manifestations.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Jia C, Lin W, Gu C, et al. Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC). Rheumatology (Oxford). 2026. PMID: 41317365. doi:10.1093/rheumatology/keaf634

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。